Quotables
"There is no reason anyone would want a computer in their home."
Ken Olsen, chairman and founder of Digital Equipment Corporation ; 1977
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7019031 | Anticancer agents based on regulation of protein prenylation Oncoproteins such as Ras and RhoB are known to induce cell division in an unrestrained manner when such proteins are localized at the inner surface of a cancer cell membrane. The localization is effected by the prenylation reaction, whereby a hydrophobic group (e.g.... | 03/28/2006 |
| 6734204 | Serotonin potentiation by oleamide analogs Analogs related to oleamide are employed for potentiating the 5-HT2A and 5-HT1A responses to serotonin (5-HT). With respect to the potentiation of the 5-HT2A receptor response, it is disclosed that, of the naturally occurring fatty a... | 05/11/2004 |
| 6689816 | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders The present invention describes a novel treatment for neuropsychiatric disorders, including anxiety disorders, mood disorders, psychotic disorders, somatoform disorders, and neuropsychiatric symptoms resulting from movement disorders. The treatment of the... | 02/10/2004 |
| 6391922 | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders The present invention describes a novel treatment for neuropsychiatric disorders, including anxiety disorders, mood disorders, psychotic disorders, somatoform disorders, and neuropsychiatric symptoms resulting from movement disorders. The treatment of the... | 05/21/2002 |
| 6197825 | Azulenyl nitrone spin trapping agents, methods of making and using same The present invention relates to chromotropic nitrone spin trapping agents, methods of making these agents, compositions comprising same, and methods of their use. In particular, azulenyl nitrones of the present invention are effective agents for trapping... | 03/06/2001 |
| 6083988 | Azulenyl nitrone spin trapping agents, methods of making and using same The present invention relates to chromotropic nitrone spin trapping agents, methods of making these agents, compositions comprising same, and methods of their use. In particular, azulenyl nitrones of the present invention are effective agents for trapping... | 07/04/2000 |
| 6066649 | Drug for cardiovascular diseases The invention relates to a drug, which contains one or more inhibitors for the cGMP-stimulated phosphodiesterase (PDE II) together with conventional substrates and/or diluents. Preferably the drug contains erythro-9-(2-hydroxy-3-nonyl)-adenine or 2-o... | 05/23/2000 |
| 6043287 | Disinfectant composition and a disinfection method using the same This invention provides a disinfectant composition which is suited to the disinfection of confined spaces such as the interior of an ambulance or the like. It is prepared extemporaneously by blending a highly concentrated alcohol with glutaraldehyde and a... | 03/28/2000 |
| 6028114 | Use of aminothiolester derivatives in pharmaceutics Use of at least one aminothiol ester derivative for the preparation of a pharmaceutical composition intended to increase the inhibition of a character resistant to the induction of apoptosis of transformed cells, this character being due to the bc12 gene ... | 02/22/2000 |
| 6020382 | Method of treating diabetes and related disease states The instant invention is concerned with acetylphenols which are useful as antiobesity and antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering or modulating triglyceride le... | 02/01/2000 |
| 5849711 | Cathepsin and methods and compositions for inhibition thereof Methods for inhibiting the secretion of ଲ-amyloid peptide (댪P) from cells comprise administering to the cells certain compounds which inhibit the activity of an approximately 31 kD protease involved in 댪P secretion. The 31 kD protease ... | 12/15/1998 |
| 5124354 | Cosmetic composition containing an aryl-substituted ethylene A composition suitable for topical application to mammalian skin or hair for inducing, maintaining or increasing hair growth comprises: (i) a special protein tyrosine kinase inhibitor; and (ii) a cosmetically acceptable vehicle for the inhibitor.... | 06/23/1992 |
| 4554156 | Wound treating agent The present invention provides a wound treating agent in powder form based on a swellable organic polymer, which comprises a cross-linked polymer of a hydrophilic acrylic or methacrylic acid derivative, which polymer is permeated by a gellable polysacchar... | 11/19/1985 |
